Sensorion

Sensorion is a biopharmaceutical company based in France dedicated to developing innovative and targeted therapeutic solutions for vestibular disorders. Sensorion's R&D pipeline includes the gene therapy development project OTOF-GT (SENS-501), SENS-401 for the treatment of sudden sensorineural hearing loss (SSNHL), and the gene therapy development project GJB2-GT for treating hearing loss caused by GJB2 gene mutations.